Graham R. Foster
Expertise in
5
conditions

Graham R. Foster

Drummond Hill, Stratherrick Road, 
Inverness, SCT, GB 
Expertise in
5
conditions
Drummond Hill, Stratherrick Road, 
Inverness, SCT, GB 
OverviewLocationsClinical Research

Overview

Graham Foster practices in Inverness, United Kingdom. Mr. Foster is highly rated in 5 conditions, according to our data. His top areas of expertise are Hepatitis, Hepatitis C, Hepatitis B, Cirrhosis, and Liver Transplant.

His clinical research consists of co-authoring 228 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Drummond Hill, Stratherrick Road, Inverness, SCT, United Kingdom
Other Locations
4 Newark Street, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Telaprevir in Patients With Genotype 3 HCV: Pilot Clinical Study to Evaluate Efficacy and Predictability of Therapy in Patients Who Have Failed to Respond to Pegylated Interferon and Ribavirin
Telaprevir in Patients With Genotype 3 HCV: Pilot Clinical Study to Evaluate Efficacy and Predictability of Therapy in Patients Who Have Failed to Respond to Pegylated Interferon and Ribavirin
Enrollment Status: Completed
Publish Date: January 05, 2023
Intervention Type: Drug
Study Drugs: Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin
Study Phase: Phase 4
A Phase IIIb, Open-label, Multicentre, International Randomised Controlled Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir (300mg)/Pibrentasvir (120mg) in Chronic HCV Treatment naïve Patients Without Cirrhosis
A Phase IIIb, Open-label, Multicentre, International Randomised Controlled Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir (300mg)/Pibrentasvir (120mg) in Chronic HCV Treatment naïve Patients Without Cirrhosis
Enrollment Status: Completed
Publish Date: December 11, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

228 Total Publications

CME: Hepatitis C.
CME: Hepatitis C.
Journal: Clinical medicine (London, England)
Published: May 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Foster's expertise for a condition
ConditionClose
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile